My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about TC Biopharm
Recent news which mentions TC Biopharm
3 Patients Already Dosed In TC BioPharm's Phase 2b Trial Of A Cutting Edge T Cell Therapy For Hard-to-Treat Cancers
January 26, 2023
Tickers
TCBP
Tags
Partner Content
Penny Stocks
Biotech
From
Benzinga
TC BioPharm Doses First 3 Patients in Phase 2b Clinical Trial of Lead Compound, OmnImmune®, To Treat Acute Myeloid Leukemia
November 22, 2022
Tickers
TCBP
TCBPW
Tags
TCBP
News
TCBPW
From
Benzinga
Gamma Delta T Cell Therapy Market Could Reach $4 Billion As Biotechs Race To Get Breakthrough Cancer Treatment Approved
November 22, 2022
Tickers
ACET
BMY
IPSC
TAK
Tags
TCBP
BMY
Market News
From
Benzinga
TC BioPharm Says It Aims To Deliver A Big Breakthrough In Cancer Treatments
August 08, 2022
Tickers
BMY
TCBP
TECH
Tags
Partner Content
Rumors
General
From
Benzinga
TC BioPharm Reports Racing Toward What Could Be A Major Cancer Immunotherapy Breakthrough
June 02, 2022
Tickers
BLUE
TCBP
Tags
Biotech
Partner Content
Penny Stocks
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.